TOUCH Prescribing Program

TYSABRI is available only through the TOUCH Prescribing Program, which stands for TYSABRI Outreach: Unified Commitment to Health.

TOUCH is a restricted distribution program focused on safety and developed with the help of the Food and Drug Administration (FDA):

  • Only prescribers and patients enrolled in the TOUCH Prescribing Program can prescribe and receive TYSABRI
  • Only certain pharmacies and infusion sites authorized by the TOUCH Prescribing Program can dispense and infuse TYSABRI

TOUCH offers more access to doctors and nurses. Your treatment is closely monitored to help make sure TYSABRI continues to be right for you:

  • Once every month at each infusion visit
  • Every 6 months by your doctor

TOUCH assigns you your own specially trained Case Manager to help:

  • Get you started on therapy and answer questions about your therapy
  • Find an authorized infusion site in your area
  • Provide information about insurance coverage and possible sources of financial assistance, if necessary

 


Important Safety Information

 

Please see full Prescribing Information, including Boxed Warning and Patient Medication Guide.

© 2008 Biogen Idec. This site is intended for residents of the United States, Puerto Rico, and US territories only.

TYSABRI® is a registered trademark and TOUCH™ is a trademark of Elan Pharmaceuticals, Inc.

BIOGEN IDEC™ is a trademark of BIOGEN IDEC.